Top Ranked Momentum Stocks to Buy for May 28th

TGT NYT JJSF WW

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 28th:

The New York Times Company (NYT - Free Report) : This news and information provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

New York Times’ shares gained 2.4% over the last one month more than S&P 500’s decline of 4%. The company possesses a Momentum Score of A.

Weight Watchers International, Inc. (WW - Free Report) : This weight management services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15% over the last 60 days.

Weight Watchers International’s shares gained 4.3% over the last one month. The company possesses a Momentum Score of A.

Target Corporation (TGT - Free Report) : This general merchandise retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.

Target's shares gained 4.9% over the last one month. The company possesses a Momentum Score of B.

J & J Snack Foods Corp. (JJSF - Free Report) : This manufacturer of nutritional snack foods and beverages has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.

J & J Snack Foods' shares gained 4.7% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>